88 related articles for article (PubMed ID: 26050654)
1. The potential application of PET/MRI to clinical Nuclear Medicine.
Freeman L; Blaufox MD
Semin Nucl Med; 2015 Jul; 45(4):267. PubMed ID: 26050654
[No Abstract] [Full Text] [Related]
2. PET/MR imaging consensus paper: a joint paper by the Society of Nuclear Medicine and Molecular Imaging Technologist Section and the Section for Magnetic Resonance Technologists.
Gilmore CD; Comeau CR; Alessi AM; Blaine M; El Fakhri GN; Hunt JK; Jordan DW; King BJ; Sicignano AJ; Stanley CT; Timpe JT; Wenzel-Lamb N
J Nucl Med Technol; 2013 Jun; 41(2):108-13. PubMed ID: 23633561
[No Abstract] [Full Text] [Related]
3. [Hybrid imaging: clinical evidence, opportunities].
Trencsényi G; Barna SK; Garai I
Orv Hetil; 2015 Dec; 156(52):2110-5. PubMed ID: 26686747
[TBL] [Abstract][Full Text] [Related]
4. On the quantification accuracy, homogeneity, and stability of simultaneous positron emission tomography/magnetic resonance imaging systems.
Schmidt H; Schwenzer NF; Bezrukov I; Mantlik F; Kolb A; Kupferschläger J; Pichler BJ
Invest Radiol; 2014 Jun; 49(6):373-81. PubMed ID: 24368614
[TBL] [Abstract][Full Text] [Related]
5. Whole body simultaneous PET/MRI: one-stop-shop?
Maseeh-uz-Zaman ; Fatima N; Sajjad Z; Zaman U
J Pak Med Assoc; 2014 Feb; 64(2):201-4. PubMed ID: 24640813
[TBL] [Abstract][Full Text] [Related]
6. Coregistered whole body magnetic resonance imaging-positron emission tomography (MRI-PET) versus PET-computed tomography plus brain MRI in staging resectable lung cancer.
Parry PV; Engh JA
Neurosurgery; 2013 Dec; 73(6):N11-3. PubMed ID: 24257336
[No Abstract] [Full Text] [Related]
7. Discrepancies and priorities in staging and restaging malignant lymphoma by SPET, SPET/CT, PET/CT and PET/MRI.
Chavdarova LI; Tzonevska AD; Piperkova EN
Hell J Nucl Med; 2013; 16(3):223-9. PubMed ID: 24137584
[TBL] [Abstract][Full Text] [Related]
8. Letter from the editor: Combining PET with MRI.
Collins J
Semin Roentgenol; 2014 Jul; 49(3):235. PubMed ID: 25497906
[No Abstract] [Full Text] [Related]
9. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
[TBL] [Abstract][Full Text] [Related]
10. A brief review of Japanese guidelines for the clinical use of (18)F-FDG-PET/MRI 2012 (Ver 1.0).
Kaneta T
Ann Nucl Med; 2013 May; 27(4):309-13. PubMed ID: 23508379
[TBL] [Abstract][Full Text] [Related]
11. Response evaluation after chemoradiotherapy for advanced nodal disease in head and neck cancer using diffusion-weighted MRI and 18F-FDG-PET-CT.
Schouten CS; de Graaf P; Alberts FM; Hoekstra OS; Comans EF; Bloemena E; Witte BI; Sanchez E; Leemans CR; Castelijns JA; de Bree R
Oral Oncol; 2015 May; 51(5):541-7. PubMed ID: 25725587
[TBL] [Abstract][Full Text] [Related]
12. [Positron emission tomography/magnetic resonance: Present and future].
Kohan AA; Vercher Conejero JL; Gaeta MC; Pelegrí Martinez L; Ros PR
Rev Esp Med Nucl Imagen Mol; 2013; 32(3):167-76. PubMed ID: 23582491
[TBL] [Abstract][Full Text] [Related]
13. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in diagnosis and management of pancreatic cancer; comparison with multidetector row computed tomography, magnetic resonance imaging and endoscopic ultrasonography.
Ergul N; Gundogan C; Tozlu M; Toprak H; Kadıoglu H; Aydin M; Cermik TF
Rev Esp Med Nucl Imagen Mol; 2014; 33(3):159-64. PubMed ID: 24140024
[TBL] [Abstract][Full Text] [Related]
14. Whole-body simultaneous positron emission tomography (PET)-MR: optimization and adaptation of MRI sequences.
Fowler KJ; McConathy J; Narra VR
J Magn Reson Imaging; 2014 Feb; 39(2):259-68. PubMed ID: 24436150
[TBL] [Abstract][Full Text] [Related]
15. FDG PET/CT: normal variations and benign findings--translation to PET/MRI.
Beheshti M; Kim CK
PET Clin; 2014 Apr; 9(2):xiii-xiv. PubMed ID: 25030290
[No Abstract] [Full Text] [Related]
16. Workflow in Simultaneous PET/MRI.
Barbosa Fde G; von Schulthess G; Veit-Haibach P
Semin Nucl Med; 2015 Jul; 45(4):332-44. PubMed ID: 26050660
[TBL] [Abstract][Full Text] [Related]
17. [Overview on instruments of PET/MRI for clinical studies and preclinical studies of small animals].
Horitsugu M
Nihon Hoshasen Gijutsu Gakkai Zasshi; 2014 Jan; 70(1):82-5. PubMed ID: 24624499
[No Abstract] [Full Text] [Related]
18. Dedicated PET device for breast PET and MRI/PET correlations.
Seiler S; Lenkinski RE
Eur J Radiol; 2012 Sep; 81 Suppl 1():S149-50. PubMed ID: 23083569
[No Abstract] [Full Text] [Related]
19. [Functional imaging: specificity of new tracers in nuclear medicine].
Vilain D; Papathanassiou D
Rev Med Interne; 2012 May; 33(5):241-3. PubMed ID: 22112833
[No Abstract] [Full Text] [Related]
20. Positron emission tomography/CT versus MRI in liver metastasis: is there a winner?
Grassetto G; Maffione AM; Rubello D
J Med Imaging Radiat Oncol; 2014 Oct; 58(5):529-31. PubMed ID: 25287485
[No Abstract] [Full Text] [Related]
[Next] [New Search]
